Integrated Profiling Identifies CCNA2 as a Potential Biomarker of Immunotherapy in Breast Cancer

INTRODUCTION: Breast cancer is the main reason for cancer-related deaths in women and the most common malignant cancer among women. In recent years, immunosuppressive factors have become a new type of treatment for cancer. However, there are no effective biomarkers for breast cancer immunotherapy. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yichao, Zhong, Qianyi, Li, Zhaoyun, Lin, Zhu, Chen, Hanjun, Wang, Pan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043851/
https://www.ncbi.nlm.nih.gov/pubmed/33859479
http://dx.doi.org/10.2147/OTT.S296373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043851/
https://www.ncbi.nlm.nih.gov/pubmed/33859479
http://dx.doi.org/10.2147/OTT.S296373

Ejemplares similares